항균제 내성 진단 시장 : 제품 유형별, 병원균 유형별, 기술별, 최종 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모 및 점유율, 예측(2025-2032년)

REPORT HIGHLIGHT

Antimicrobial Resistance Diagnostics Market size was valued at US$ 4,610.22 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Antimicrobial Resistance (AMR) Diagnostics Market is the global industry that focuses on developing, producing, and selling diagnostic tools and technologies to detect antimicrobial-resistant pathogens. These diagnostics help identify resistance patterns in bacteria, viruses, fungi, and parasites. This information allows healthcare providers to prescribe effective treatments and prevent inappropriate use of antimicrobials. The market includes molecular diagnostics, immunoassays, microbiology techniques, and rapid point of care tests used in clinical, hospital, and research settings. As antimicrobial resistance rises worldwide and becomes a serious public health threat, the demand for timely and accurate AMR diagnostics is increasing significantly. This growth is driving innovation and investment in the field.

Antimicrobial Resistance Diagnostics Market- Market Dynamics

Increased adoption of rapid and point-of-care diagnostic technologies to enable timely treatment decisions

Rapid and point-of-care (POC) diagnostic technologies play a crucial role in combating antimicrobial resistance by enabling healthcare professionals to quickly identify resistant infections and tailor treatments accordingly. Unlike conventional laboratory tests that may take days, these advanced diagnostics provide results within minutes or hours, which helps prevent the overuse and misuse of antibiotics.

According to a 2023 World Health Organization (WHO) report, the use of rapid diagnostics has been shown to reduce unnecessary antibiotic prescriptions by up to 30-40%, significantly limiting the development of resistance. Additionally, faster and more accurate detection improves patient outcomes by facilitating timely, targeted therapies, reducing hospital stays, and curbing the spread of infections in healthcare facilities. The increasing availability of portable POC devices also ensures that even remote and resource-limited settings can access critical diagnostic capabilities, bolstering global efforts to contain antimicrobial resistance.

For Instance,

In March 2025, Abbott Laboratories launched a new rapid molecular diagnostic test capable of detecting multiple antimicrobial-resistant pathogens within an hour. This test enhances hospital infection control by enabling quick identification and isolation of resistant infections, improving patient management and antibiotic stewardship.

Antimicrobial Resistance Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on product type segmentation, reagents & consumables was predicted to show maximum market share in the year 2024

Based on pathogen type segmentation, methicillin-resistant staphylococcus aureus (MRSA) was the leading pathogen type in 2024

Based on technology segmentation, polymerase chain reaction (PCR) was the leading technology in 2024

Based on end use segmentation, hospitals was the leading end use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Antimicrobial Resistance Diagnostics Market- Segmentation Analysis:

The global antimicrobial resistance diagnostics market is segmented on the basis of product type, pathogen type, technology, end use and region.

The market is divided into two categories based on product type: reagents & consumables and instruments. The reagents & consumables sector dominates the market. These components are essential for the testing process, unlike instruments that you might only buy once in a while. Reagents and consumables are needed for every single diagnostic test, which means there's a constant and reliable demand. Healthcare facilities and labs are always on the lookout to restock their supplies to keep their testing operations running smoothly. Reagents and consumables work well with different diagnostic platforms, including molecular diagnostics, immunoassays, and culture-based methods. This broad compatibility increases their use in various testing environments. As a result, hospitals, diagnostic labs, and point-of-care facilities consistently need these products. New technology in diagnostics often results in the creation of new reagents designed for specific tests, which grows the market even more. The pricing models for reagents and consumables benefit manufacturers since consumables provide steady revenue, unlike the less frequent sales of instruments.

The market is divided into five categories based on end-use: hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, research institutes and others. The hospitals sector dominates the market and this dominance stems from hospitals being the primary points of care where infections are frequently diagnosed and treated. Due to the high risk of hospital-acquired infections and the critical need to manage antimicrobial resistance, hospitals invest heavily in advanced diagnostic tools to ensure timely and accurate detection of resistant pathogens. Moreover, hospitals often have the infrastructure, trained personnel, and funding to implement sophisticated AMR diagnostics, driving substantial demand. Their role in infection control programs and antibiotic stewardship further underscores their importance as a key end user in this market.

Antimicrobial Resistance Diagnostics Market- Geographical Insights

North America dominates the global antimicrobial resistance diagnostics market, holding a 45.71% market share in 2024.

North America remains the largest and most mature market for antimicrobial resistance diagnostics, supported by advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending. The presence of leading diagnostic companies, coupled with comprehensive antimicrobial stewardship programs and government-backed initiatives such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria, has accelerated the adoption of sophisticated diagnostic tools. Hospitals and clinical laboratories in this region prioritize early and accurate detection of resistant pathogens to improve patient outcomes and reduce healthcare-associated infections. Additionally, strong reimbursement frameworks and regulatory support further drive market growth by encouraging investment in innovative diagnostics.

Asia Pacific is estimated to register the highest CAGR in the antimicrobial resistance diagnostics market during the forecast period in 2024.

The Asia-Pacific region, meanwhile, is the fastest-growing market due to a confluence of factors including a rapidly expanding population, increasing urbanization, and rising incidence of infectious diseases with resistant strains. Countries such as China, India, Japan, and South Korea are experiencing significant improvements in healthcare infrastructure, with increased focus on infectious disease management and diagnostic capacity. Governments in the region are actively launching awareness campaigns and implementing policies to monitor and control AMR, which boost demand for rapid and cost effective diagnostic solutions. Moreover, the growing middle class population and improved access to healthcare facilities create a larger patient base seeking timely diagnosis and treatment. The combination of rising prevalence of multidrug-resistant infections, greater healthcare funding, and partnerships between local and international diagnostic firms positions Asia-Pacific as a high-potential market with robust growth prospects over the coming decade.

Antimicrobial Resistance Diagnostics Market- Competitive Landscape:

The antimicrobial resistance (AMR) diagnostics market features a competitive landscape characterized by the presence of several global and regional players focusing on innovation, strategic collaborations, and product launches to strengthen their market position. Leading companies invest heavily in research and development to introduce rapid, accurate, and cost-effective diagnostic solutions that cater to the growing demand for timely detection of resistant pathogens.

Key players in the market include Roche Diagnostics, Abbott Laboratories, bioMerieux, Danaher Corporation (Cepheid), QIAGEN, and Thermo Fisher Scientific. These companies leverage their extensive product portfolios and strong distribution networks to maintain a competitive edge. They also engage in partnerships with healthcare institutions and governments to expand their market reach and support AMR surveillance programs.

The market is marked by frequent technological advancements such as the development of multiplex molecular assays and point of care testing platforms, which provide faster and more precise results. Additionally, mergers and acquisitions are common strategies employed to enhance capabilities and enter new markets. Overall, competition drives continuous innovation, ensuring better diagnostic accuracy and patient outcomes in the fight against antimicrobial resistance.

Recent Developments:

In March 2025, bioMerieux received FDA 510(k) clearance for its VITEK COMPACT PRO, a next-generation system combining microorganism identification and antibiotic susceptibility testing. This launch enhances clinical labs' capabilities to rapidly detect resistant pathogens, thereby supporting targeted treatments and improving patient management in the fight against AMR

In July 2024, QIAGEN announced a collaboration with a global healthcare provider to deploy its QIAstat-Dx Analyzer in regional clinics for rapid AMR diagnostics. This partnership aims to improve access to quick and accurate resistance testing outside traditional hospital settings, supporting early intervention

In September 2024, Thermo Fisher Scientific launched a new PCR-based diagnostic kit designed to rapidly detect antimicrobial-resistant pathogens in hospital settings. This innovation strengthens Thermo Fisher's position in the AMR diagnostics space by offering fast, accurate testing critical for effective antibiotic stewardship

In July 2022, Boehringer Ingelheim, a leading research-driven biopharmaceutical company, along with the life sciences company Evotec SE and bioMerieux, announced a joint venture to develop the next generation of antimicrobials and actionable diagnostics to combat AMR. This collaboration helped the company broaden its product offerings for AMR diagnosis

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Abbott Laboratories
• Accelerated Diagnostics, USA
• Alifax
• BD
• Beckman Coulter
• Becton, Dickinson and Company
• BioMerieux
• Bio-Rad Laboratories
• Danaher
• F. Hoffmann-La Roche
• GeneFluidics
• Hologic, Inc.
• Molsid
• OpGen
• Roche Diagnostics
• Thermo Fisher Scientific
• Vela Diagnostics
• Visby Medical, Inc.
• Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Reagents & Consumables
• Instruments

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032

• Clostridium difficile (CD)
• Drug-resistant campylobacter (DRC)
• Drug-resistant Neisseria gonorrhoeae (DRNG)
• Drug-resistant streptococcus pneumoniae (DRSP)
• Methicillin-resistant Staphylococcus aureus (MRSA)
• Other pathogen types

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

• Immunoassay
• Mass spectrometry
• Microbiology culture
• Next generation sequencing (NGS)
• Polymerase chain reaction (PCR)
• Rapid & point of care
• Other technologies

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

• Diagnostic Laboratories
• Hospitals
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Antimicrobial Resistance Diagnostics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Antimicrobial Resistance Diagnostics Market Snippet by Product Type
  • 2.1.2. Antimicrobial Resistance Diagnostics Market Snippet by Pathogen Type
  • 2.1.3. Antimicrobial Resistance Diagnostics Market Snippet by Technology
  • 2.1.4. Antimicrobial Resistance Diagnostics Market Snippet by End Use
  • 2.1.5. Antimicrobial Resistance Diagnostics Market Snippet by Country
  • 2.1.6. Antimicrobial Resistance Diagnostics Market Snippet by Region
• 2.2. Competitive Insights

3. Antimicrobial Resistance Diagnostics Key Market Trends

• 3.1. Antimicrobial Resistance Diagnostics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Antimicrobial Resistance Diagnostics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Antimicrobial Resistance Diagnostics Market Opportunities
• 3.4. Antimicrobial Resistance Diagnostics Market Future Trends

4. Antimicrobial Resistance Diagnostics Industry Study

• 4.1. PESTEL Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Antimicrobial Resistance Diagnostics Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Antimicrobial Resistance Diagnostics Market Landscape

• 6.1. Antimicrobial Resistance Diagnostics Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Antimicrobial Resistance Diagnostics Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
  • 7.1.2. Reagents & Consumables
  • 7.1.3. Instruments

8. Antimicrobial Resistance Diagnostics Market - By Pathogen Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
  • 8.1.2. Clostridium difficile (CD)
  • 8.1.3. Drug-resistant campylobacter (DRC)
  • 8.1.4. Drug-resistant Neisseria gonorrhoeae (DRNG)
  • 8.1.5. Drug-resistant streptococcus pneumoniae (DRSP)
  • 8.1.6. Methicillin-resistant Staphylococcus aureus (MRSA)
  • 8.1.7. Other pathogen types

9. Antimicrobial Resistance Diagnostics Market - By Technology

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
  • 9.1.2. Immunoassay
  • 9.1.3. Mass spectrometry
  • 9.1.4. Microbiology culture
  • 9.1.5. Next generation sequencing (NGS)
  • 9.1.6. Polymerase chain reaction (PCR)
  • 9.1.7. Rapid & point of care
  • 9.1.8. Other technologies

10. Antimicrobial Resistance Diagnostics Market - By End Use

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
  • 10.1.2. Diagnostic Laboratories
  • 10.1.3. Hospitals
  • 10.1.4. Pharmaceutical & Biotechnology Companies
  • 10.1.5. Research Institutes
  • 10.1.6. Others

11. Antimicrobial Resistance Diagnostics Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Antimicrobial Resistance Diagnostics Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Antimicrobial Resistance Diagnostics Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Abbott Laboratories
  • 12.2.2. Accelerated Diagnostics, USA
  • 12.2.3. Alifax
  • 12.2.4. BD
  • 12.2.5. Beckman Coulter
  • 12.2.6. Becton, Dickinson and Company
  • 12.2.7. BioMerieux
  • 12.2.8. Bio-Rad Laboratories
  • 12.2.9. Danaher
  • 12.2.10. F. Hoffmann-La Roche
  • 12.2.11. GeneFluidics
  • 12.2.12. Hologic, Inc.
  • 12.2.13. Molsid
  • 12.2.14. OpGen
  • 12.2.15. Roche Diagnostics
  • 12.2.16. Thermo Fisher Scientific
  • 12.2.17. Vela Diagnostics
  • 12.2.18. Visby Medical, Inc.
  • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us